YWHAB |
YWHAB: 14-3-3 protein beta/alpha |
STK3 |
STK3, MST2: Serine/threonine-protein kinase 3 |
4.012 |
Evidence |
|
STAM2 |
STAM2: Signal transducing adapter molecule 2 |
PSMA3 |
PSMA3, PSC8: Proteasome subunit alpha type-3 |
4.012 |
Evidence |
|
FRS3 |
FRS3: Fibroblast growth factor receptor substrate 3 |
GAPD |
GAPDH, GAPD, CDABP0047, OK/SW-cl.12: Glyceraldehyde-3-phosphate dehydrogenase |
4.012 |
Evidence |
|
NFKBIA |
NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha |
MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
4.012 |
Evidence |
|
SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
BARD1 |
BARD1: BRCA1-associated RING domain protein 1 |
4.012 |
Evidence |
|
PABPC1 |
PABPC1, PAB1, PABP1, PABPC2: Polyadenylate-binding protein 1 |
WDR79 |
IPI00306087 |
4.012 |
Evidence |
|
MSH6 |
MSH6, GTBP: DNA mismatch repair protein MSH6 |
CDK6 |
CDK6: Cell division protein kinase 6 |
4.012 |
Evidence |
|
RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
TSC1 |
TSC1, KIAA0243, TSC: Hamartin |
4.012 |
Evidence |
|
RPS6KA5 |
RPS6KA5, MSK1: Ribosomal protein S6 kinase alpha-5 |
WWOX |
WWOX, FOR, WOX1: WW domain-containing oxidoreductase |
4.012 |
Evidence |
|
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
CREBBP |
CREBBP, CBP: CREB-binding protein |
4.012 |
Evidence |
|
EXOSC2 |
EXOSC2, RRP4: Exosome complex exonuclease RRP4 |
CLTC |
CLTC, CLH17, CLTCL2, KIAA0034: Clathrin heavy chain 1 |
4.012 |
Evidence |
|
STMN1 |
STMN1, LAP18, OP18: Stathmin |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
4.012 |
Evidence |
|
HIST1H4A |
HIST1H4A, H4/A, HIST1H4B, H4/I, H4/G, HIST1H4D, H4/B, H4/J, HIST1H4F, HIST4H4, H |
MEF2D |
MEF2D: Myocyte-specific enhancer factor 2D |
4.012 |
Evidence |
|
SP1 |
SP1, TSFP1: Transcription factor Sp1 |
DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
4.012 |
Evidence |
|
COL1A2 |
COL1A2: Collagen alpha-2(I) chain precursor |
EIF2S3 |
EIF2S3, EIF2G: Eukaryotic translation initiation factor 2 subunit 3 |
4.012 |
Evidence |
|
CRYAB |
CRYAB, CRYA2: Alpha-crystallin B chain |
HMGA1 |
HMGA1, HMGIY: High mobility group protein HMG-I/HMG-Y |
4.012 |
Evidence |
|
SEMG1 |
SEMG1, SEMG: Semenogelin-1 precursor |
SERPIND1 |
SERPIND1, HCF2: Heparin cofactor 2 precursor |
4.012 |
Evidence |
|
SUPT5H |
SUPT5H, SPT5, SPT5H: Transcription elongation factor SPT5 |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
4.002 |
Evidence |
|
SUPT5H |
SUPT5H, SPT5, SPT5H: Transcription elongation factor SPT5 |
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
4.002 |
Evidence |
|
APOL1 |
APOL1, APOL: Apolipoprotein-L1 precursor |
GGCX |
GGCX, GC: Vitamin K-dependent gamma-carboxylase |
4.002 |
Evidence |
|
EIF3S4 |
EIF3S4: Eukaryotic translation initiation factor 3 subunit 4 |
NULL |
Putative uncharacterized protein (Fragment) |
4.002 |
Evidence |
|
HLA-DMB |
HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec |
NULL |
HLA-B, HLAB: HLA class I histocompatibility antigen, B-39 alpha chain precursor |
3.997 |
Evidence |
|
B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
HLA-DPB1 |
HLA class II histocompatibility antigen, SB beta chain (Fragment) |
3.997 |
Evidence |
|
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
FES |
Proto-oncogene c-fes variant 3 |
3.997 |
Evidence |
|
NULL |
HLA-B, HLAB: HLA class I histocompatibility antigen, B-67 alpha chain precursor |
HLA-DMA |
DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP |
3.997 |
Evidence |
|